DS_10.1177_2381468318796218 – Supplemental material for Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden

Angelis, Aris

doi:10.25384/SAGE.7092869.v1

DS_10.1177_2381468318796218.pdf (508.66 kB)

DS_10.1177_2381468318796218 – Supplemental material for Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden

journal contribution

posted on 2018-09-15, 12:00 authored by Aris Angelis

Supplemental material, DS_10.1177_2381468318796218 for Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden by Aris Angelis in MDM Policy & Practice